Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Adaptimmune Ther Ads (NQ: ADAP )

4.930 USD -0.110 (-2.18%)
Official Closing Price Updated: 5:32 PM EDT, Apr 16, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 756,920
Open 5.030
Bid (Size) 4.810 (3)
Ask (Size) 5.010 (2)
Prev. Close 5.040
Today's Range 4.810 - 5.030
52wk Range 3.110 - 13.40
Shares Outstanding 930,827,670
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Adaptimmune Reports Fourth Quarter / Full Year 2020 Financial Results and Business Update
From GlobeNewswire News Releases
Adaptimmune to Report Fourth Quarter/ Full Year 2020 Financial Results and Business Updates on Thursday, February 25, 2021
From GlobeNewswire News Releases

Performance

YTD
-17.97%
-17.97%
1 Month
-7.68%
-7.68%
3 Month
-19.18%
-19.18%
6 Month
-37.59%
-37.59%
1 Year
+49.39%
+49.39%

More News

Read More
Adaptimmune to Showcase Market Potential for SPEAR T-cell Portfolio and Pipeline with Multiple Cell Therapy Platforms During Virtual Investor Day
From GlobeNewswire News Releases
Durable Responses with ADP-A2M4 in Synovial Sarcoma with Confirmed Responses in 44% of Patients and Disease Control Rate of 94% Presented at CTOS
From GlobeNewswire News Releases
The Implied Analyst 12-Month Target For MOON
Tags ETFs
From ETF Channel
5 Best Penny Stocks To Buy Now According To Insiders
Tags Market News
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Adaptimmune to Host Virtual Investor Day on Friday, November 20th
From GlobeNewswire News Releases
First Week of ADAP May 21st Options Trading
Tags Stocks
From Market News Video
Two Confirmed Responses and Five out of Six Patients with Initial Tumor Reductions from Early Dose Cohorts of SURPASS Trial, Presented at SITC
From GlobeNewswire News Releases
12 Health Care Stocks Moving In Wednesday's After-Market Session
Tags OPGN Benzinga INVO
From Benzinga
Thinking about buying stock in Oramed Pharmaceuticals, Mogo, Chiasma, Adaptimmune Therapeutics, or Dynatronics?
From PR Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.